GARADACIMAB

garadacimab 200 mg/1.2 mL injection, 1.2 mL pen device

GARADACIMAB (15305M)

garadacimab 200 mg/1.2 mL injection, 1.2 mL pen device
15305M
Body System:
Manner of administration:Injection
General Schedule
Authority Required

Restriction

Indication: Chronic treatment of hereditary angioedema Types 1 or 2
Treatment phase: Continuing preventative treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 5 DPMQ: $30,148.49 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Andembry